FDA approves first generic versions of Singulair to treat asthma, allergies
11:06 EDT 3 Aug 2012 | FDA
The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.
Original Article: FDA approves first generic versions of Singulair to treat asthma, allergies
More From BioPortfolio on "FDA approves first generic versions of Singulair to treat asthma, allergies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
